World’s Largest Facility of its Kind Noted for Superior Project Execution Using Modular Construction
Fluor Corporation (NYSE: FLR) announced today that Grifols’ North
Fractionation Facility in Clayton, N.C., was named the International
Society for Pharmaceutical Engineering (ISPE) 2014 Facility of the Year
for Project Execution.
Fluor provided integrated engineering, procurement, construction
management and front-end qualification for this 150,000-square-foot
plasma fractionation facility, which was built using modular
construction techniques to meet an aggressive construction schedule,
incorporate new centrifuge technology and expand existing plant
utilities.
“Fluor provides project management and execution excellence for
pharmaceutical and biotech clients across the globe, and the Grifols
blood plasma facility in North Carolina is a great example of successful
outcomes,” said Juan G. Hernandez, president of Industrial Services for
Fluor. “We provided Grifols with a single point of project
accountability, continuity of intent and elimination of redundant
project functions that resulted in a state-of-the-art facility.”
“Grifols has very high standards, and we can always rely upon the same
high standards from Fluor in delivering our project execution needs,”
said Detlef Kehm, Grifols vice president of engineering. “I am
personally very pleased with ISPE’s independent validation of this
superior project and with Fluor’s performance.”
ISPE’s judging panel was impressed with the delivery of the facility in
an aggressive time frame and under budget. This was achieved with a high
degree of collaboration within the teams and because of early and
consistent collaboration with European and North American regulatory
agencies, which facilitated the qualification and validation process.
Grifols’ North Fractionation Facility in North Carolina is the world’s
largest and most technologically advanced of its kind. It operates with
a closed and fully automated manufacturing process in an ambient
environment to deliver life sciences products in the safest, quality
conscious and efficient manner. The primary project achievements
included the following:
-
Provided a high-throughput manufacturing facility while ensuring
superior product quality
-
Maximized yields while maintaining product quality
-
Lowered long-term operational costs
-
Delivered the facility in an aggressive timeframe and under budget
Fluor-led projects have been chosen by ISPE for Facility of the Year
awards three times over the past five years.
For more details and a video on the Grifols North Fractionation Facility
project, visit http://www.fluor.com/about_fluor/Pages/videos.aspx?channel=4&videoid=115.
About Grifols
Grifols is a global healthcare company with a 70-year legacy of
improving people's health and wellbeing through the development of
life-saving plasma medicines, diagnostics systems and hospital pharmacy
products. Additionally, Grifols has established an independent
engineering company, Grifols Engineering, SA. The company is present in
more than 100 countries worldwide and is headquartered in Barcelona,
Spain. In 2013, sales exceeded 2,740 million euros with a headcount of
13,200 employees. The company's class A shares are listed on the Spanish
Stock Exchange, where they are part of the Ibex-35 (MCE:GRF). Its
non-voting class B shares are listed on the Mercado Continuo (MCE:GRF.P)
and on the U.S. NASDAQ via ADRs (NASDAQ: GRFS). For more information,
visit www.grifols.com.
About Fluor Corporation
Fluor Corporation (NYSE: FLR) is a global engineering and construction
firm that designs and builds some of the world's most complex projects.
The company creates and delivers innovative solutions for its clients in
engineering, procurement, fabrication, construction, maintenance and
project management on a global basis. For more than a century, Fluor has
served clients in the energy, chemicals, government, industrial,
infrastructure, mining and power market sectors. Headquartered in
Irving, Texas, Fluor ranks 110 on the FORTUNE 500 list. With more than
40,000 employees worldwide, the company's revenue for 2013 was $27.4
billion. Visit Fluor at www.fluor.com
and follow on Twitter @FluorCorp.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140410006329/en/
Fluor CorporationMedia Relations:Brian Mershon, 469-398-7621orEric Krantz, 281-263-6030orInvestor Relations:Ken Lockwood, 469-398-7220orJason Landkamer, 469-398-7222